pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Virtual connections. Engagement channels. Joanna Carlish.

Regulation 77

Regulation Marketing Sales Branding 77

Pharma Marketing Network

JULY 12, 2023

The pharmaceutical industry is facing a number of challenges, including increasing competition, rising costs, and changing regulations. In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. They are individuals with unique needs, concerns, and experiences.

Marketing 98

Marketing Compliance Regulation Branding 98

Pharmaceutical Technology

JULY 26, 2022

According to GlobalData’s recent Niemann-Pick Type C (NPC): Opportunity Analysis and Forecast to 2031 report, the NPC market is expected to see significant growth during 2021–31. This sales growth will be in line with a steadily increasing disease prevalence and the entrance of novel agents into the market.

Marketing 306

Marketing Gene Branding Sales 306

Pharmaceutical Technology

NOVEMBER 21, 2022

Japan is currently the fourth largest market in the world. Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Other reasons include lower sales demand and high investment costs.

Marketing 130

Marketing Sales Manufacturing Drugs 130

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical companies hold permission to market their products directly to consumers. The direct-to-consumer marketing companies for pharmaceuticals are increasingly moving online as it supports the digitisation of information, enabling patients to take control of their health. No product is mentioned for help-seeking advertising.

Marketing 130

Marketing Compliance Doctors Doctor 130

pharmaphorum

OCTOBER 11, 2022

An explosion of digital mental health tools being offered for sale has presented regulators with a problem – how should they be classified and assessed for safety or efficacy? ” The post Wellcome funds work on regulating digital mental health tools appeared first on. . The healthcare charity is providing £1.8

Regulation 95

Regulation Production Development Sales 95

Pharma Marketing Network

OCTOBER 14, 2023

In this article, we will explore the challenges of balancing privacy concerns with targeted ads in pharma marketing. In many countries, there are laws in place that regulate the use of personal data. This can help companies reach more potential customers and increase their sales.

Marketing 97

Marketing Compliance Sales Production 97

XTalks

JULY 7, 2023

Earlier this week, the World Health Organization (WHO) released new guidelines that emphasized the critical role that marketers must play in safeguarding children’s health. The WHO underscored the need for tighter regulations to protect children from the adverse effects of food marketing.

Marketing 97

Marketing Production Regulation Branding 97

BioPharma Reporter

APRIL 25, 2024

Back in 2014, AstraZeneca and Merck were the first to receive FDA approval for their PARP inhibitor Lynparza (olaparib) for use in breast cancer gene (BRCA)-mutated metastatic ovarian cancer patients.

FDA Approval 98

FDA Approval Sales Marketing Gene 98

Outsourcing Pharma

SEPTEMBER 8, 2023

has seen sales grow by triple digits and has received more than 100 orders since its launch in March 2022. A benchtop DNA sequencer developed by the U.S. DNA sequencing company Element Biosciences, Inc.,

DNA 93

DNA Sales Development Regulation 93

Pharma in Brief

AUGUST 9, 2021

On July 31, 2021, Health Canada published a Notice of Intent outlining its plan to amend the Food and Drug Regulations ( FDR ) and the Medical Devices Regulations in the spring of 2022. Health Canada is accepting comments on the Minister of Health’s proposal to amend the FDR and the Medical Devices Regulations until October 28, 2021.

Regulation 98

Regulation Drugs Manufacturing Production 98

pharmaphorum

JULY 29, 2021

billion in sales from its COVID-19 vaccine Vaxzevria in the first half of this year, but making it available at no profit had weighed on its profit margins. A delayed FDA filing – held up by data requests from the US regulator – should take place before the end of the year, according to the CEO. billion from its one-dose vaccine.

Sales 98

Sales Vaccination Vaccine Regulation 98

BioTech 365

APRIL 7, 2021

Beiersdorf Aktiengesellschaft / Key word(s): Development of Sales Beiersdorf Aktiengesellschaft: Sales growth in the first quarter of 2021 above capital markets expectations 07-Apr-2021 / 14:24 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) … Continue reading →

Sales 40

Sales Marketing Regulation Development 40

XTalks

SEPTEMBER 12, 2022

Food and beverage companies across the supply chain must always be prepared for new regulatory developments in 2022 as they seek to bring new ingredients and products to market. New regulations are often reflective of the supply chain, food safety and consumer trends. Regulating Heavy Metals in Baby Food.

Regulation 52

Regulation Production Contamination Marketing 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

Packaging plays a vital role in maintaining the quality, safety, user-friendliness and marketability of drugs and other pharmaceutical products. Finding the best commercial packaging suppliers in contract marketing. Finding the best commercial packaging suppliers in contract marketing.

Packaging 130

Packaging Packaging Marketing Containment 130

pharmaphorum

AUGUST 8, 2022

As we reported this morning, the deal gives Pfizer already-approved SCD therapy Oxbryta (voxelator) – which industry watchers reckon could see a dramatic uptick in sales with Pfizer’s marketing muscle – plus a phase 3 antibody candidate, a phase 1 follow-up to Oxbryta that could offer improved dosing.

Marketing 103

Marketing Sales Gene Editing Antibody 103

BioPharma Reporter

JANUARY 18, 2024

Despite the current Bruton tyrosine kinase (BTK) inhibitor market being valued at approximately $6 billion, sales specifically for chronic lymphocytic leukemia (CLL) are predicted to be nearly $5 billion by 2032 in the seven major markets.

Marketing 52

Marketing Sales Regulation 52

XTalks

FEBRUARY 8, 2024

Understanding the market dynamics of diabetes treatments becomes crucial for professionals across these industries. The top 15 diabetes drugs in 2023, according to 2022 sales data, reflect the current state of diabetes management and hint at the evolving needs and trends within this critical area of healthcare. billion in Q4 2022.

Sales 52

Sales Insulin FDA Approval Drugs 52

BioPharma Reporter

AUGUST 1, 2022

GSKâs first quarter following the demerger of its consumer health business sees the company raise its 2022 sales guidance to between 6-8%, up from 5-7% on its previous estimation.

Sales 98

Sales Regulation Marketing 98

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. Capturing market share. Better customer experience. billion in 2021 to $9.23

Marketing 98

Marketing Life Science Sales Branding 98

Pharmaceutical Technology

JUNE 21, 2023

Ketarx will be marketed under the FDA-approved label of ketamine and in dosages that include 10mg/ml, 50mg/ml and 100mg/ml, with the option to boost the concentration and ready-to-administer applications. PharmaTher and Vitruvias Therapeutics have entered a collaboration deal to commercialise PharmaTher’s Ketarx (racemic ketamine) in the US.

FDA Approval 130

FDA Approval Sales Marketing Regulation 130

pharmaphorum

OCTOBER 28, 2022

The EU regulator has formally started an accelerated assessment of GSK’s RSV vaccine RSVPreF3 OA for older adults, with a decision now expected in the third quarter of next year – a timeline that could allow GSK to beat rival RSV shot developers, including Pfizer, to the European market.

Regulation 52

Regulation Vaccination Vaccine Sales 52

pharmaphorum

APRIL 30, 2021

It’s fair to say this is the most interesting time ever for market access. A recent analysis delves into the challenges companies face in getting digital health technologies reimbursed and presents recommendations for how they can find a smoother path to market. Time for a NICE change. How will NICE fare in a post-Brexit world?

Marketing 81

Marketing Sales Regulation Pharma Companies 81

pharmaphorum

NOVEMBER 22, 2022

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market. Sales have been modest to date – just £36 million in the third quarter – despite it being the first drug targeting BCMA to reach the market.

Marketing 105

Marketing Trials Antibody Clinical Trials 105

XTalks

JANUARY 31, 2023

The US Department of Agriculture (USDA) recently updated its organic food regulations to tighten guidelines around organic products. Oftentimes, when dealing with imports and exports of “organic” products, bills of sales and documents may be forged somewhere along the way, resulting in fraudulent labeling and mislead consumers.

Regulation 52

Regulation Production Bacteria Packaging 52

Pharma Marketing Network

AUGUST 9, 2023

The pharmaceutical industry operates in a highly regulated environment, where marketing and advertising practices are subject to rigorous scrutiny. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.

Marketing 52

Marketing Compliance Packaging Packaging 52

FDA Law Blog

SEPTEMBER 26, 2023

(HP&M), a leader in providing legal and regulatory support to the life sciences industries, today announced the appointment of Jeff Grizzel to the newly created position of Chief Marketing Officer (CMO). Jeff joins HP&M from Compliance Architects where he served as Vice President of Business Development.

Marketing 59

Marketing Life Science Compliance Business Development 59

Outsourcing Pharma

OCTOBER 11, 2023

Small molecule drugs are carving a significant niche in lung cancer treatment, according to data and analytics company, GlobalData, and Tagrisso is well on its way to dominating the market.

Sales 86

Sales Drugs Marketing Regulation 86

Pharma in Brief

MAY 4, 2023

The Ontario Superior Court ( ONSC ) has dismissed a claim for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the Regulations ) brought by Apotex Inc. Apotex ) for lost sales of its Apo-Atomoxetine product. Canadian Patent No. Apotex filed an ANDS for its generic Apo-Atomoxetine product.

Regulation 52

Regulation Sales Production Compliance 52

World of DTC Marketing

FEBRUARY 7, 2022

According to Endpoint News” We’ve seen Biogen’s CSO exit under pressure in recent weeks, and senior marketing execs leave in an exodus as the company recoiled from a fierce backlash against the FDA’s ultra controversial approval of Aduhelm for Alzheimer’s. Finally, they need to withdraw Aduhelm from the market.

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

World of DTC Marketing

OCTOBER 5, 2021

last year gave away more than $23 billion in rebates to insurance intermediaries, but still netted $50 billion in sales. sales of the 20 top-selling drugs worldwide totaled $101.1 billion while sales to the rest of the world totaled nearly $57 billion. sales of the 20 top-selling drugs worldwide totaled $101.1

Sales 241

Sales Drugs Manufacturing Production 241

XTalks

JULY 13, 2023

The World Health Organization (WHO) recently released new guidelines that emphasized the critical role that marketers must play in safeguarding children’s health. The marketing of food products that are high in saturated and trans fats, free sugars and/or salt, known as HFSS, has been a subject of debate.

Marketing 52

Marketing Regulation Branding Sales 52

FDA Law Blog

AUGUST 15, 2021

Shapiro — A determination of “intended use” is fundamental to FDA’s regulation of drugs and medical devices. It is a primary basis for determining if an article is regulated by FDA at all, and if so, what regulatory requirements apply. Thus ends a saga that began with a proposal in 2015 to amend the “intended use” regulation.

Regulation 93

Regulation Manufacturing Drugs Marketing 93

XTalks

FEBRUARY 13, 2024

Food advertisements play a crucial role in shaping consumer choices, influencing dining habits and driving sales. However, the line between enticing marketing and misleading information can sometimes blur, leading to controversies and legal actions.

Marketing 59

Marketing Containment Production Packaging 59

BioPharma Reporter

MAY 31, 2023

Sales of branded anti-obesity drugs (AOB) could hit $44 billion in 2030 vs. $2.5 billion in 2022, with just under 70% stemming from the US, according to a report from Bloomberg Intelligence.

Sales 52

Sales Branding Drugs Regulation 52

pharmaphorum

AUGUST 10, 2021

Europe market has proved so hostile to gene therapies when it comes to pricing and reimbursement for gene therapies that bluebird bio has decided to quit the market altogether, according to Andrew Obenshain, president of its severe genetic diseases unit. market and will wind down in Europe. market and will wind down in Europe.

Gene Therapy 135

Gene Therapy Gene Marketing Genetic Disease 135

Pharma Marketing Network

AUGUST 9, 2023

The pharmaceutical industry operates in a highly regulated environment, where marketing and advertising practices are subject to rigorous scrutiny. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.

Marketing 40

Marketing Compliance Packaging Packaging 40